News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Axonyx Inc. Reports Fourth Quarter And Full Year 2005 Financial Results
March 17, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--March 16, 2006--Axonyx, Inc. (NASDAQ: AXYX) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2005.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
IPO
Apnimed eyes up to $160M IPO to prep for sleep apnea drug launch
July 28, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
Oak Hill takes SPAC track to Nasdaq with Roche asset in tow
July 28, 2026
·
2 min read
·
Tristan Manalac
FDA
UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy
July 27, 2026
·
3 min read
·
Heather McKenzie
Business
Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail
July 27, 2026
·
3 min read
·
Gabrielle Masson